⌘K

10:43:30·350d

SECFilingvia Quantisnow

Amendment: SEC Form SCHEDULE 13G/A filed by Third Harmonic Bio Inc.

ByQuantisnow·Wall Street's wire, on your screen.

THRD· Third Harmonic Bio Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

THRD
Third Harmonic Bio Inc.
Health Care

Recent analyst ratings

Mar 28UpdateStifel$5.00
Feb 12UpdateMorgan Stanley$5.00
Feb 11UpdateRaymond James-
Aug 9UpdateMorgan Stanley$20.00
Jun 18UpdateStifel$23.00
Jun 7UpdateRaymond James$18.00

Related

INSIDER255d
CEO Holles Natalie C. disposed of 1,218,836 shares, closing all direct ownership in the company (SEC Form 4)
INSIDER255d
Director Seidel Hans Martin disposed of 85,753 shares, closing all direct ownership in the company (SEC Form 4)
INSIDER255d
SEC Form 4 filed by Director Soloway Thomas P
INSIDER255d
Director Iwicki Mark T disposed of 128,631 shares, closing all direct ownership in the company (SEC Form 4)
INSIDER255d
SEC Form 4 filed by Chief Financial & Bus. Officer Murphy Christopher M.
INSIDER255d
SEC Form 4 filed by Director Gladstone Michael
INSIDER255d
Director Bonita David P disposed of 5,779,071 shares, closing all direct ownership in the company (SEC Form 4)
SEC259d
SEC Form 15-12G filed by Third Harmonic Bio Inc.